Drug intelligence / Profile preview

chymotrypsin

Development stage
Phase 4
Modality
Replacement Enzymes → Therapeutic Enzymes → Recombinant Proteins and Enzymes
Administration
Oral, Parenteral, Ophthalmic, Inhalation, Intranasal, Topical
01

Overview

Chymotrypsin is a serine protease enzyme synthesized in the pancreas and secreted as an inactive precursor (chymotrypsinogen), which is activated in the duodenum. It acts as a digestive enzyme by catalyzing the hydrolysis of peptide bonds in proteins and polypeptides—preferentially those with aromatic amino acids such as tryptophan, tyrosine or phenylalanine on the N-terminal side. In medicine and supplements it is used for its anti-inflammatory and anti-edematous properties to reduce swelling associated with trauma or surgery and to promote tissue repair. It has also been used during cataract surgery to reduce damage to ocular tissues[2][3][4][6]. The mechanism of action involves proteolytic cleavage of protein substrates via a catalytic triad (ser195-his57-asp102) at its active site[6].

Brand names
Catarase
Other names
A-ChymotrypsinA-ChymotrypsineAlpha-ChymotrypsinAlpha-ChymotrypsineChymotrypsin AChymotrypsine AChymotrypsin BChymotrypsine BChymotrypsineChymotrypsinumL-ChymotrypsinL-ChymotrypsineQuimotripsina

Beyond the preview

Go deeper on chymotrypsin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on chymotrypsin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call